| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 65.58B | 64.44B | 58.23B | 52.89B | 49.89B | 49.15B |
| Gross Profit | 13.45B | 12.96B | 10.97B | 9.33B | 8.81B | 9.12B |
| EBITDA | 4.99B | 4.67B | 4.02B | 3.23B | 3.07B | 3.45B |
| Net Income | 3.26B | 3.10B | 2.73B | 1.94B | 2.82B | 2.00B |
Balance Sheet | ||||||
| Total Assets | 45.64B | 48.57B | 42.95B | 37.56B | 35.14B | 34.91B |
| Cash, Cash Equivalents and Short-Term Investments | 10.64B | 9.00B | 6.99B | 6.58B | 7.25B | 6.69B |
| Total Debt | 3.60B | 3.65B | 1.73B | 1.02B | 887.00M | 1.22B |
| Total Liabilities | 19.43B | 22.44B | 18.73B | 15.85B | 14.65B | 14.52B |
| Stockholders Equity | 26.01B | 25.93B | 24.04B | 21.54B | 20.34B | 20.27B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.64B | 762.00M | 368.00M | 1.49B | 2.55B |
| Operating Cash Flow | 0.00 | 4.96B | 2.42B | 921.00M | 1.78B | 2.73B |
| Investing Cash Flow | 0.00 | -3.47B | -1.80B | -697.00M | 971.00M | -267.00M |
| Financing Cash Flow | 0.00 | 378.00M | -287.00M | -1.02B | -2.37B | -1.81B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥55.73B | 20.65 | ― | 3.33% | 9.63% | 11.40% | |
75 Outperform | ¥37.16B | 9.65 | 10.19% | 3.21% | 6.55% | 5.32% | |
71 Outperform | ¥11.77B | 14.99 | ― | 1.08% | 18.17% | 191.50% | |
69 Neutral | ¥300.58B | 14.55 | 30.73% | 2.20% | 4.52% | ― | |
67 Neutral | ¥22.16B | 14.17 | ― | 1.34% | 16.06% | 31.24% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | ¥283.52B | 44.54 | ― | 0.87% | 16.30% | 23.34% |